D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$501M |
| 2 |
Booking.com
BKNG
|
+$470M |
| 3 |
Qualcomm
QCOM
|
+$398M |
| 4 |
Chevron
CVX
|
+$268M |
| 5 |
Meta Platforms (Facebook)
META
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$914M |
| 2 |
Netflix
NFLX
|
+$305M |
| 3 |
Johnson & Johnson
JNJ
|
+$244M |
| 4 |
McDonald's
MCD
|
+$241M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.56% |
| 2 | Consumer Discretionary | 12.42% |
| 3 | Healthcare | 10.21% |
| 4 | Financials | 8.66% |
| 5 | Industrials | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TELL
3001
DELISTED
Tellurian Inc.
TELL
| $553K | ﹤0.01% |
61,641
+43,713
| +244% | +$360K |
|
3002
Enanta Pharmaceuticals
ENTA
$372M
| $551K | ﹤0.01% |
6,450
-25,815
| -80% | -$2.59M |
|
3003
American Superconductor
AMSC
$1.48B
| $549K | ﹤0.01% |
79,057
+62,973
| +392% | +$376K |
|
3004
Riverview Bancorp
RVSB
$107M
| $548K | ﹤0.01% |
62,002
+13,476
| +28% | +$124K |
|
3005
Prothena Corp
PRTA
$458M
| $547K | ﹤0.01% |
41,799
-14,787
| -26% | -$214K |
|
|
SVM
3006
Silvercorp Metals
SVM
$2.13B
| $547K | ﹤0.01% |
223,600
+103,200
| +86% | +$274K |
|
3007
Gorman-Rupp
GRC
$2.16B
| $545K | ﹤0.01% |
14,929
+477
| +3% | +$17.5K |
|
3008
PUT
Huntsman Corp
HUN
$2.24B
| $545K | ﹤0.01% |
+20,000
| New | +$609K |
|
3009
CALL
Ventas
VTR
$48.9B
| $544K | ﹤0.01% |
+10,000
| New | +$579K |
|
|
EGLE
3010
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $544K | ﹤0.01% |
13,819
+2,225
| +19% | +$84.3K |
|
3011
Nelnet
NNI
$4.79B
| $543K | ﹤0.01% |
9,503
-233
| -2% | -$13.6K |
|
3012
OrthoPediatrics
KIDS
$485M
| $541K | ﹤0.01% |
14,770
-6,370
| -30% | -$195K |
|
3013
CALL
O-I Glass
OI
$1.39B
| $541K | ﹤0.01% |
28,800
+10,600
| +58% | +$191K |
|
|
NITE
3014
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
| $541K | ﹤0.01% |
+26,487
| New | +$544K |
|
|
AIFU
3015
CALL
AIFU Inc
AIFU
$201M
| $540K | ﹤0.01% |
50
| – | – |
|
|
ECHO
3016
DELISTED
Echo Global Logistics, Inc.
ECHO
| $539K | ﹤0.01% |
17,417
-42,900
| -71% | -$1.4M |
|
3017
StoneX
SNEX
$8.83B
| $538K | ﹤0.01% |
56,371
-4,632
| -8% | -$49.3K |
|
|
HUD
3018
DELISTED
Hudson Ltd. Class A Common Shares
HUD
| $538K | ﹤0.01% |
+23,862
| New | +$463K |
|
3019
Enovis
ENOV
$1.56B
| $537K | ﹤0.01% |
8,649
-38,201
| -82% | -$2.18M |
|
|
VER
3020
DELISTED
VEREIT, Inc.
VER
| $537K | ﹤0.01% |
14,787
-75,922
| -84% | -$2.89M |
|
3021
Badger Meter
BMI
$3.66B
| $536K | ﹤0.01% |
+10,123
| New | +$527K |
|
|
EEX
3022
DELISTED
Emerald Holding
EEX
| $536K | ﹤0.01% |
+32,537
| New | +$566K |
|
3023
Noodles & Co
NDLS
$90.5M
| $535K | ﹤0.01% |
5,526
+2,590
| +88% | +$240K |
|
|
FLIC
3024
DELISTED
First of Long Island Corp
FLIC
| $533K | ﹤0.01% |
24,500
+1,699
| +7% | +$38.8K |
|
|
PTLA
3025
PUT
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $533K | ﹤0.01% |
+20,000
| New | +$653K |
|
Similar funds
D.E. Shaw & Co's Q3 2018 Portfolio in Review
As of Q3 2018, D.E. Shaw & Co held 4,167 positions worth $83.2B, up 8.6% from $76.7B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
D.E. Shaw & Co's Q3 2018 filing shows 494 new, 1,413 increased, 1,463 reduced and 484 closed positions. Its largest new stake was Six Flags Entertainment Corp.: 850,069 shares worth $59.4M. The largest sale was Apple, an estimated $914M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q3 2018 buy was Six Flags Entertainment Corp.: 850,069 shares worth $59.4M.
- D.E. Shaw & Co added most to AT&T in Q3 2018, an estimated $501M increase.
- D.E. Shaw & Co's biggest Q3 2018 reduction was Apple, cutting an estimated $914M.
- D.E. Shaw & Co fully exited RH in Q3 2018, selling an estimated $43.2M.
- D.E. Shaw & Co's ten largest holdings make up 9.5% of its $83.2B portfolio in Q3 2018.
- D.E. Shaw & Co opened 494 new positions and closed 484 in Q3 2018.
- D.E. Shaw & Co's portfolio value rose 8.6% quarter-over-quarter to $83.2B.
Based on D.E. Shaw & Co's 13F filing for Q3 2018, filed 14 Nov 2018.